Cholesterol Biosynthesis and Homeostasis in Regulation of the Cell Cycle

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Singh, Pushpendra ^a   Saxena, Roopali ^a   Srinivas, Gunda ^a   Pande, Gopal ^a   Chattopadhyay, Amitabha ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(2 CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE; MEVINOLIN; TRIPARANOL;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL SIZE; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; FAT CONTENT; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HOMEOSTASIS; LIPID MEMBRANE; NONHUMAN; RAT; STEROL ANALYSIS; STRUCTURE ANALYSIS;

ANIMALS; CELL CYCLE; CELL LINE; CELL SIZE; CHOLESTEROL; G1 PHASE CELL CYCLE CHECKPOINTS; HOMEOSTASIS; LIPID METABOLISM; LOVASTATIN; RATS; TRIPARANOL;

EID: 84875025174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058833     Document Type: Article

References (57)

1. Schafer KA, (1998) The cell cycle: A review. Vet Pathol 35: 461-478.
2. Chen HW, Kandutsch AA, Waymouth C, (1974) Inhibition of cell growth by oxygenated derivatives of cholesterol. Nature 251: 419-421.
3. Chen HW, Heiniger HJ, Kandutsch AA, (1975) Relationship between sterol synthesis and DNA synthesis in phytohemagglutinin-stimulated mouse lymphocytes. Proc Natl Acad Sci USA 72: 1950-1954.
4. Brown MS, Goldstein JL, (1974) Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7- ketocholesterol. J Biol Chem 249: 7306-7314.
5. Bloch KE, (1983) Sterol structure and membrane function. CRC Crit Rev Biochem 14: 47-92.
6. Singh P, Paila YD, Chattopadhyay A, (2007) Differential effects of cholesterol and 7-dehydrocholesterol on the ligand binding activity of the hippocampal serotonin1A receptor: implications in SLOS. Biochem Biophys Res Commun 358: 495-499.
7. Singh P, Saxena R, Paila YD, Jafurulla M, Chattopadhyay A, (2009) Differential effects of cholesterol and desmosterol on the ligand binding function of the hippocampal serotonin1A receptor: Implications in desmosterolosis. Biochim Biophys Acta 1788: 2169-2173.
8. Keyomarsi K, Sandoval L, Band V, Pardee AB, (1991) Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 51: 3602-3609.
9. Chakrabarti R, Engleman EG, (1991) Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation. J Biol Chem 266: 12216-12222.
10. Istvan ES, Deisenhofer J, (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292: 1160-1164.
11. Menge T, Hartung H-P, Stüve O, (2005) Statins: A cure-all for the brain? Nat Rev Neurosci 6: 325-331.
12. Shrivastava S, Pucadyil TJ, Paila YD, Ganguly S, Chattopadhyay A, (2010) Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin1A receptors. Biochemistry 49: 5426-5435.
13. Pande G, Kumar NA, Manogaran PS, (1996) Flow cytometric study of changes in the intracellular free calcium during the cell cycle. Cytometry 24: 55-63.
14. Kennady PK, Ormerod MG, Singh S, Pande G, (2004) Variation of mitochondrial size during the cell cycle: A multiparameter flow cytometric and microscopic study. Cytometry A 62: 97-108.
15. Amundson DM, Zhou M, (1999) Fluorometric method for the enzymatic determination of cholesterol. J Biochem Biophys Methods 38: 43-52.
16. McClare CWF, (1971) An accurate and convenient organic phosphorus assay. Anal Biochem 39: 527-530.
17. Greenspan P, Mayer EP, Fowler SD, (1985) Nile Red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol 100: 965-973.
18. Dean PN, Jett JH, (1974) Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 60: 523-527.
19. Fox MH, (1980) A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. Cytometry 1: 71-77.
20. Paila YD, Murty MRVS, Vairamani M, Chattopadhyay A, (2008) Signaling by the human serotonin1A receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome. Biochim Biophys Acta 1778: 1508-1516.
21. Chevy F, Illien F, Wolf C, Roux C, (2002) Limb malformations of rat fetuses exposed to a distal inhibitor of cholesterol biosynthesis. J Lipid Res 43: 1192-1200.
22. Sánchez-Wandelmer J, Dávalos A, de la Peña G, Cano S, Giera M, et al. (2010) Haloperidol disrupts lipid rafts and impairs insulin signaling in SH-SY5Y cells. Neuroscience 167: 143-153.
23. Dvornik D, Kraml M, Dubuc J, Givner M, Gaudry R, (1963) A novel mode of inhibition of cholesterol biosynthesis. J Am Chem Soc 85: 3309.
24. Langan TJ, Volpe JJ, (1987) Cell cycle-specific requirement for mevalonate, but not for cholesterol, for DNA synthesis in glial primary cultures. J Neurochem 49: 513-552.
25. Siperstein MD, (1984) Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth. J Lipid Res 25: 1462-1468.
26. Quesney-Huneeus V, Galick HA, Siperstein MD, Erickson SK, Spencer TA, et al. (1983) The dual role of mevalonate in the cell cycle. J Biol Chem 258: 378-385.
27. Fernández C, Martín M, Gómez-Coronado D, Lasunción MA, (2005) Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression. J Lipid Res 46: 920-929.
28. Martínez-Botas J, Ferruelo AJ, Suárez Y, Fernández C, Gómez-Coronado D, et al. (2001) Dose-dependent effects of lovastatin on cell cycle progression. Distinct requirement of cholesterol and non-sterol mevalonate derivatives. Biochim Biophys Acta 1532: 185-194.
29. Fernández C, Lobo M, Gómez-Coronado D, Lasunción MA, (2004) Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation. Exp Cell Res 300: 109-120.
30. Suárez Y, Fernández C, Ledo B, Martín M, Gómez-Coronado D, et al. (2005) Sterol stringency of proliferation and cell cycle progression in human cells. Biochim Biophys Acta 1734: 203-213.
31. Pucadyil TJ, Chattopadhyay A, (2006) Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res 45: 295-333.
32. Gimpl G, Wiegand V, Burger K, Fahrenholz F, (2002) Cholesterol and steroid hormones: modulators of oxytocin receptor function. Prog Brain Res 139: 43-55.
33. Paila YD, Chattopadhyay A, (2010) Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem 51: 439-466.
34. Nguyen MM, Nguyen ML, Caruana G, Bernstein A, Lambert PF, et al. (2003) Requirement of PDZ-containing proteins for cell cycle regulation and differentiation in the mouse lens epithelium. Mol Cell Biol 23: 8970-8981.
35. Ranganathan R, Ross EM, (1997) PDZ domain proteins: Scaffolds for signaling complexes. Curr Biol 7: R770-R773.
36. Kwik J, Boyle S, Fooksman D, Margolis L, Sheetz MP, et al. (2003) Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4,5-bisphosphate-dependent organization of cell actin. Proc Natl Acad Sci USA 100: 13964-13969.
37. Ganguly S, Chattopadhyay A, (2010) Cholesterol depletion mimics the effect of cytoskeletal destabilization on membrane dynamics of the serotonin1A receptor: a zFCS study. Biophys J 99: 1397-1407.
38. Porter JA, Young KE, Beachy PA, (1996) Cholesterol modification of Hedgehog signaling proteins in animal development. Science 274: 255-259.
39. Cooper MK, Wassif CA, Krakowiak PA, Taipale J, Gong R, et al. (2003) A defective response to hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 33: 508-513.
40. Riobó NA, Lu K, Ai X, Haines GM, Emerson CP, (2006) Phosphoinositide 3-kinase and Akt are essential for sonic hedgehog signaling. Proc Natl Acad Sci USA 103: 4505-4510.
41. Shiojima I, Walsh K, (2002) Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90: 1243-1250.
42. Song G, Ouyang G, Bao S, (2005) The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9: 59-71.
43. Du X, Kristiana I, Wong J, Brown AJ, (2006) Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. Mol Biol Cell 17: 2735-2745.
44. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, et al. (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci USA 100: 12027-12032.
45. Chauhan NB, (2003) Membrane dynamics, cholesterol homeostasis and Alzheimer's disease. J Lipid Res 44: 2019-2029.
46. Sumi S, Beauchamp RD, Townsend CM, Uchida T, Murakami M, et al. (1992) Inhibition of pancreatic adenocarcinoma cell growth by lovastatin. Gastroenterology 103: 982-989.
47. Narisawa T, Fukaura Y, Terada K, Umezawa A, Tanida N, et al. (1994) Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice. Carcinogenesis 15: 2045-2048.
48. Hawk MA, Cesen KT, Siglin JC, Stoner GD, Ruch RJ, (1996) Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin. Cancer Lett 109: 217-222.
49. Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, et al. (1996) Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res 2: 483-491.
50. Brown AJ, (2007) Cholesterol, statins and cancer. Clin Exp Pharmacol Physiol 34: 135-141.
51. Kritchevsky SB, Kritchevsky D, (1992) Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr 12: 391-416.
52. Pipalia NH, Cosner CC, Huanga A, Chatterjee A, Bourbon P, et al. (2011) Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts. Proc Natl Acad Sci USA 108: 5620-5625.
53. Vance JE, Hayashi H, Karten B, (2005) Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol 16: 193-212.
54. Papakostas GI, Öngür D, Iosifescu DV, Mischoulon D, Fava M, (2004) Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol 14: 135-142.
55. Martin M, Dotti CG, Ledesma MD, (2010) Brain cholesterol in normal and pathological aging. Biochim Biophys Acta 1801: 934-944.
56. Porter FD, (2008) Smith-Lemli-Opitz syndrome: pathogenesis diagnosis and management. Eur J Hum Genet 16: 535-541.
57. Porter FD, Herman GE, (2011) Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res 52: 6-34.